OHRP Ohr Pharmaceuticals Inc.

0.71
+0.02  (2%)
Previous Close 0.69
Open 0.70
Price To book 1.42
Market Cap 39910114
Shares 56,211,428
Volume 12,238
Short Ratio 3.01
Av. Daily Volume 258,744

SEC filingsSee all SEC filings

  1. 8-K - Current report 171147623
  2. 8-K - Current report 171128696
  3. EFFECT - Notice of Effectiveness 171105474
  4. CORRESP [Cover] - Correspondence
  5. CORRESP [Cover] - Correspondence

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Phase 3 data due early 2018.
OHR-102 (MAKO)
Neovascular (Wet) Age-related Macular Degeneration (AMD)
Phase 2 data released July 2015
OHR-102
Retinal vein occlusion (CRVO)

SEC Filings

  1. 8-K - Current report 171147623
  2. 8-K - Current report 171128696
  3. EFFECT - Notice of Effectiveness 171105474
  4. CORRESP [Cover] - Correspondence
  5. CORRESP [Cover] - Correspondence
  6. UPLOAD [Cover] - SEC-generated letter
  7. 8-K - Current report 171088577
  8. S-3 - Registration statement under Securities Act of 1933 171088562
  9. 10-Q - Quarterly report [Sections 13 or 15(d)] 171015809
  10. 8-K - Current report 171014865